While you may think of research only involving scientists in a lab, our clinical trials allow you participate hands-on in the latest medical innovations. Clinical trials at Banner Research are used to evaluate a new drug or treatment. Carefully conducted clinical trials are the fastest and safest way to find treatments and to improve health.
Participation from patients like you in clinical trials will continue to lead to new and better treatments for disease. Banner Research is dedicated to conducting research ethically, safely and efficiently and that patients are protected throughout the clinical trials process.
Learn about clinical trials available at these locations:
A patient’s participation in any Banner Health research study is voluntary.
For every study in which a patient participates, they receive a document called "Consent to Participate in a Clinical Research Study" that explains the study in straightforward language. A research team member discusses the protocol with the patient, explains its details, and answers their questions.
It is the patient’s responsibility to understand the protocol. They are encouraged to discuss the protocol with family and friends. They are not hurried into making a decision. They are asked to sign the document only after they understand the nature of the protocol and agree to the commitment.
As further protection, at any time after signing the protocol, a patient is free to change their mind and decide not to participate further. This means that they are free to withdraw from the study completely, or to refuse particular treatments or tests. Sometimes, however, this will make a patient ineligible to continue the study.
Research studies are generally divided into four phases:
Phase I trials are designed to confirm the safety of a new medication. Phase I trials generally involve a small group of healthy volunteers and typically last three to four months.
Phase II trials help to confirm whether or not a medication is effective. These studies are “randomized”. Randomization means that participants are divided into two groups—one group receives the active treatment and the other group receives a “control”. (Usually the standard treatment available).
Phase III trials are initiated once a treatment has demonstrated both safety and efficacy. Phase III trials help determine whether a medication is effective over a longer period of time. These trials are longer and larger, in terms of the number of participants. Phase III trials can provide enough data for a product to be submitted for approval by the Food and Drug Administration (FDA).
Phase IV clinical trials are conducted to obtain more information on a new medicine that has been submitted to the FDA for approval. Phase IV trials are also conducted when a company is gathering more information about a product already on the market.